World's Best Scientists 2026 revealed!
Moses R. Kamya

Moses R. Kamya

D-Index & Metrics

Medicine

D-Index
88
Citations
28653
World Ranking
13153
National Ranking
3

Moses R. Kamya publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Moses R. Kamya sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 814 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Moses R. Kamya D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Moses R. Kamya sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Moses R. Kamya is affiliated with Makerere University in Uganda and has a research focus rooted primarily in medicine, with extensive work in public health, infectious diseases, epidemiology, immunology, and pediatrics. The scientist's body of work includes studies addressing malaria, mosquito-borne diseases, HIV/AIDS interventions, maternal and child health, adolescent reproductive health, and tuberculosis research.

The scientist has contributed to multiple high-impact publications with recent notable papers including:

  • Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study (2021, The Lancet Infectious Diseases)
  • Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda (2020, The Journal of Infectious Diseases)
  • Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign (2020, The Lancet)
  • Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda (2023, New England Journal of Medicine)
  • Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study (2020, The Lancet HIV)

Frequent coauthors who have collaborated extensively with Moses R. Kamya include:

  • Grant Dorsey
  • Diane V. Havlir
  • Joaniter I. Nankabirwa
  • Emmanuel Arinaitwe
  • Jane Kabami

The scientist's work has been published frequently in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Malaria Journal
  • PLoS ONE
  • Research Square (Research Square)
  • PLOS Global Public Health

Moses R. Kamya's main fields of study encompass medicine with a significant emphasis on various subfields, particularly public health, environmental and occupational health, infectious diseases, epidemiology, immunology, and pediatrics. Their research addresses critical topics, including:

  • Malaria Research and Control
  • Mosquito-borne diseases and control
  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • Global Maternal and Child Health
  • Adolescent Sexual and Reproductive Health
  • Tuberculosis Research and Epidemiology

Best Publications

  • Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV Therapy in Resource-Limited Settings

    David B. Meya;Yukari C. Manabe;Yukari C. Manabe;Barbara Castelnuovo;Bethany A. Cook

  • Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy

    Andrew Kambugu;David B. Meya;Joshua Rhein;Meagan O'Brien

  • Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.

    Adoke Yeka;Anne Gasasira;Arthur Mpimbaza;Jane Achan

  • Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy

    Abel Kakuru;Prasanna Jagannathan;Mary K. Muhindo;Paul Natureeba

  • Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda

    Maxwell Kilama;David L Smith;Robert Hutchinson;Ruth Kigozi

  • Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.

    Danica A. Helb;Kevin K. A. Tetteh;Philip L. Felgner;Jeff Skinner

  • HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa

    Diane V Havlir;Laura B Balzer;Edwin D Charlebois;Tamara D Clark

  • Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 Genes and Clinical Response to Chloroquine in Kampala, Uganda

    Grant Dorsey;Moses R. Kamya;Ajay Singh;Philip J. Rosenthal

  • Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study

    Frederik van Gemert;Bruce Kirenga;Niels Chavannes;Moses Kamya

  • Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.

    Grant Dorsey;Sarah Staedke;Tamara D. Clark;Denise Njama-Meya

  • Malaria Transmission, Infection, and Disease at Three Sites with Varied Transmission Intensity in Uganda: Implications for Malaria Control

    Moses R. Kamya;Emmanuel Arinaitwe;Humphrey Wanzira;Agaba Katureebe

  • Effect of HIV-1 Infection on Antimalarial Treatment Outcomes in Uganda: A Population-Based Study

    Moses R. Kamya;Anne F. Gasasira;Adoke Yeka;Nathan Bakyaita

  • Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.

    Grant Dorsey;Denise Njama;Moses R Kamya;Adithya Cattamanchi

  • Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial

    Moses R Kamya;Adoke Yeka;Hasifa Bukirwa;Myers Lugemwa

  • Factors Determining the Heterogeneity of Malaria Incidence in Children in Kampala, Uganda

    Tamara D. Clark;Bryan Greenhouse;Denise Njama-Meya;Bridget Nzarubara

  • Neurocognitive and Motor Deficits in HIV-Infected Ugandan Children With High CD4 Cell Counts

    Theodore D. Ruel;Michael J. Boivin;Hannah E. Boal;Paul Bangirana

  • A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial

    Daniel Atwine;Betty Balikagala;Quique Bassat;Victor Chalwe

  • Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.

    Adoke Yeka;Grant Dorsey;Moses R. Kamya;Ambrose Talisuna

  • The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data

    Jane Achan;Ishag Adam;Emmanuel Arinaitwe;Elizabeth A. Ashley

  • SHORT REPORT: PROXIMITY TO MOSQUITO BREEDING SITES AS A RISK FACTOR FOR CLINICAL MALARIA EPISODES IN AN URBAN COHORT OF UGANDAN CHILDREN

    Sarah G. Staedke;E. Willis Nottingham;Jonathan Cox;Moses R. Kamya

Frequent Co-Authors

Grant Dorsey
Grant Dorsey University of California, San Francisco
Diane V. Havlir
Diane V. Havlir University of California, San Francisco
Edwin D. Charlebois
Edwin D. Charlebois University of California, San Francisco
Philip J. Rosenthal
Philip J. Rosenthal University of California, San Francisco
Sarah G. Staedke
Sarah G. Staedke Liverpool School of Tropical Medicine
Bryan Greenhouse
Bryan Greenhouse University of California, San Francisco
Elizabeth A. Bukusi
Elizabeth A. Bukusi University of Washington
Chris Drakeley
Chris Drakeley London School of Hygiene & Tropical Medicine
Isabel Rodriguez-Barraquer
Isabel Rodriguez-Barraquer University of California, San Francisco
Teun Bousema
Teun Bousema Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking flexible education options, online pathways are increasingly popular. Advancements in technology now make it easier to complete key nursing degrees without stepping into a traditional classroom, offering more accessible and affordable alternatives to medical school.

For registered nurses, cheap rn to bsn online programs offer a cost-effective way to advance careers and boost earning potential. Similarly, online adn programs can be a stepping stone for those starting their nursing journey, often with flexible schedules and easier admissions.

Non-nurses looking to enter advanced practice can explore direct entry online msn programs. These allow career changers to earn a master’s in nursing without a prior healthcare background. There’s also the opportunity to reach the highest academic level with online nursing phd programs—ideal for those interested in research, academia, or leadership roles.

Together, these online programs offer diverse entry points and specializations, allowing students to align education with specific career goals in the evolving U.S. healthcare system.

Best Scientists Citing Moses R. Kamya

Trending Scientists

Recently Published Articles